Your browser doesn't support javascript.
loading
Neoadjuvant PD-1 inhibitor combines with chemotherapy versus neoadjuvant chemotherapy in resectable squamous cell carcinoma of the lung.
Feng, Yuan; Sun, Wei; Zhang, Jie; Wang, Yang; Chen, Jinfeng; Liu, Xinying; Wang, Liang; Li, Shaolei; Lv, Chao; Lu, Fangliang; Zhang, Jianzhi; Hong, Yang; Xiao, Shanshan; Wang, Tao; Jiao, Raymond; Wang, Ziping; Qi, Liping; Li, Nan; Yang, Yue; Lin, Dongmei; Fang, Jian.
Affiliation
  • Feng Y; Department of Thoracic Surgery II, Peking University Hospital (Beijing Cancer Hospital and Institute), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of Oncology, Beijing, China.
  • Sun W; Department of Pathology, Peking University Hospital (Beijing Cancer Hospital and Institute), Beijing, China.
  • Zhang J; Department of Thoracic Oncology II, Peking University Hospital (Beijing Cancer Hospital and Institute), Beijing, China.
  • Wang Y; Department of Thoracic Oncology II, Peking University Hospital (Beijing Cancer Hospital and Institute), Beijing, China.
  • Chen J; Department of Thoracic Surgery II, Peking University Hospital (Beijing Cancer Hospital and Institute), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of Oncology, Beijing, China.
  • Liu X; Department of Pathology, Peking University Hospital (Beijing Cancer Hospital and Institute), Beijing, China.
  • Wang L; Department of Thoracic Surgery II, Peking University Hospital (Beijing Cancer Hospital and Institute), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of Oncology, Beijing, China.
  • Li S; Department of Thoracic Surgery II, Peking University Hospital (Beijing Cancer Hospital and Institute), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of Oncology, Beijing, China.
  • Lv C; Department of Thoracic Surgery II, Peking University Hospital (Beijing Cancer Hospital and Institute), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of Oncology, Beijing, China.
  • Lu F; Department of Thoracic Surgery II, Peking University Hospital (Beijing Cancer Hospital and Institute), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of Oncology, Beijing, China.
  • Zhang J; Department of Thoracic Surgery II, Peking University Hospital (Beijing Cancer Hospital and Institute), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of Oncology, Beijing, China.
  • Hong Y; Department of Thoracic Surgery II, Peking University Hospital (Beijing Cancer Hospital and Institute), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of Oncology, Beijing, China.
  • Xiao S; Hangzhou Repugene Technology Inc., Zhejiang, China.
  • Wang T; Hangzhou Repugene Technology Inc., Zhejiang, China.
  • Jiao R; Panovue Biological Technology Co. Ltd, Beijing, China.
  • Wang Z; Department of Thoracic Oncology I, Peking University Hospital (Beijing Cancer Hospital and Institute), Beijing, China.
  • Qi L; Department of Radiology, Peking University Hospital (Beijing Cancer Hospital and Institute), Beijing, China.
  • Li N; Department of Nuclear Medicine, Peking University Hospital (Beijing Cancer Hospital and Institute), Beijing, China.
  • Yang Y; Department of Thoracic Surgery II, Peking University Hospital (Beijing Cancer Hospital and Institute), Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University School of Oncology, Beijing, China.
  • Lin D; Department of Pathology, Peking University Hospital (Beijing Cancer Hospital and Institute), Beijing, China.
  • Fang J; Department of Thoracic Oncology II, Peking University Hospital (Beijing Cancer Hospital and Institute), Beijing, China.
Thorac Cancer ; 13(3): 442-452, 2022 02.
Article in En | MEDLINE | ID: mdl-34913597
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Lung Neoplasms Limits: Humans Language: En Journal: Thorac Cancer Year: 2022 Document type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Lung Neoplasms Limits: Humans Language: En Journal: Thorac Cancer Year: 2022 Document type: Article Affiliation country: China